A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis (Q73393150)
Jump to navigation
Jump to search
scientific article published on 01 December 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis |
scientific article published on 01 December 2000 |
Statements
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis (English)
Braybrooke JP
O'Byrne KJ
Propper DJ
Blann A
Saunders M
Dobbs N
Han C
Woodhull J
Mitchell K
Crew J
Smith K
Stephens R
Ganesan TS
Talbot DC
1 December 2000